TransMedics to Present at Upcoming September Investor Conferences

Rhea-AI Summary

TransMedics (NASDAQ: TMDX), a medical technology company focused on organ transplant therapy, has announced its participation in two upcoming investor conferences in New York this September.

Management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 10:00 a.m. EST, followed by a presentation at the Baird 2025 Global Healthcare Conference on September 9, 2025, at 12:15 p.m. EST. Both presentations will be available via webcast on the company's investor relations website.

ANDOVER, Mass., Aug. 25, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Morgan Stanley 23^rd Annual Global Healthcare Conference in New York on Monday, September 8, 2025, at 10:00 a.m. EST and present at the Baird 2025 Global Healthcare Conference in New York on Tuesday, September 9, 2025, at 12:15 p.m. EST.

Event: Morgan Stanley 23^rd Annual Global Healthcare Conference
Date: Monday, September 8, 2025
Time: 10:00 a.m. EST

Event: Baird 2025 Global Healthcare Conference
Date: Tuesday, September 9, 2025
Time: 12:15 p.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-september-investor-conferences-302537760.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the Morgan Stanley Healthcare Conference 2025?

TransMedics will participate in a fireside chat at the Morgan Stanley conference on Monday, September 8, 2025, at 10:00 a.m. EST in New York.

What time is TransMedics (TMDX) presenting at the Baird Global Healthcare Conference?

TransMedics will present at the Baird conference on Tuesday, September 9, 2025, at 12:15 p.m. EST in New York.

Where can I watch TransMedics (TMDX) investor conference presentations?

The presentations will be available via live and archived webcast on the Investors section of TransMedics' website at investors.transmedics.com.

What does TransMedics (TMDX) company do?

TransMedics is a medical technology company that develops organ transplant therapy solutions for patients with end-stage lung, heart, and liver failure.